YaSheng Group
HERB · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 14.2% | 13.7% | 32.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 33.5% | 33.3% | 30.1% | 28.6% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 31.7% | 35.1% | 28% | 26.8% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 33.4% | 33.2% | 28.6% | 26.5% |
| EPS Diluted | 0.051 | 0.045 | 0.034 | 0.022 |
| % Growth | 15% | 32% | 57.2% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |